Hyperkalemia

Patiromer With or Without Food for the Treatment of Hyperkalemia
NCT02694744 | PHASE 4 | INTERVENTIONAL

The purpose of this study is to evaluate the efficacy and safety of patiromer administered once daily (QD) when given with food compared to without food (experimental treatment group) for the treatment of hyperkalemia (high potassium in the blood).

Trial Information
29 Sites
114 Participants
Recruiting
18 Years to 65 Years

If interested, contact clinicaltrials@cslbehring.com for more information

CSL Behring respects your privacy. For an explanation of how CSL Behring will use the information you are submitting, please view our Privacy Policy

SUBMIT
Investigator Site
Fountain Valley,California,United States,92708
Investigator Site
Huntington Beach,California,United States,92648
Investigator Site
Palm Springs,California,United States,92262
Investigator Site
Riverside,California,United States,92505
Investigator Site
San Dimas,California,United States,91773
Investigator Site
Denver,Colorado,United States,80230
Investigator Site
Edgewater,Florida,United States,32132
Investigator Site
Hialeah,Florida,United States,33012
Investigator Site
Hollywood,Florida,United States,33021
Investigator Site
Lauderdale Lakes,Florida,United States,33313
Investigator Site
Lauderdale Lakes,Florida,United States,33319
Investigator Site
Miami,Florida,United States,33015
Investigator Site
Miami,Florida,United States,33147
Investigator Site
Pembroke Pines,Florida,United States,33028
Investigator Site
Tampa,Florida,United States,33614
Investigator Site
Meridian,Idaho,United States,83642
Investigator Site
Aurora,Illinois,United States,60504
Investigator Site
Flint,Michigan,United States,48504
Investigator Site
Kansas City,Missouri,United States,64111
Investigator Site
Las Vegas,Nevada,United States,89106
Investigator Site
Flushing,New York,United States,11355
Investigator Site
Norman,Oklahoma,United States,73069
Investigator Site
Jackson,Tennessee,United States,38305
Investigator Site
Dallas,Texas,United States,75231
Investigator Site
San Antonio,Texas,United States,78202
Investigator Site
San Antonio,Texas,United States,78207
Investigator Site
San Antonio,Texas,United States,78215
Investigator Site
San Antonio,Texas,United States,78229
Investigator Site
Salt Lake City,Utah,United States,84124

Study Eligibility Criteria

Additional Studies

Additional studies can be found at ClinicalTrials.gov